Parkman Healthcare Partners LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1777015
STAMFORD, CT
Position in NBIX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,051,350
-$3,218,252 QoQ
Shares Held
99,069
-13.6% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
1.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Parkman Healthcare Partners LLC holds $90,125,176 across 8 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (14.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
280,575 | $21,576,217 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,708,099 | $16,261,102 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
99,069 | $13,051,350 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
259,184 | $12,479,709 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,721,264 | $9,983,331 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
621,458 | $8,638,266 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
85,062 | $4,396,854 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
300,752 | $3,738,347 |
All Filings in NBIX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,051,350 | 99,069 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,269,602 | 114,712 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $19,908,972 | 141,822 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $20,865,796 | 166,010 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $18,623,049 | 168,382 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,796,735 | 115,727 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $14,960,164 | 129,840 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $15,855,453 | 115,170 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $18,198,681 | 131,951 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $18,461,684 | 140,116 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,432,562 | 83,845 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $13,177,010 | 139,735 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $22,049,562 | 217,838 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $13,894,813 | 116,333 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $12,469,054 | 117,400 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,343,215 | 85,589 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,928,187 | 63,234 | Shares | Sole | 2022-05-13 | |
| 2020-09-30 | $12,745,431 | 132,544 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $14,826,172 | 121,526 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $11,123,925 | 128,526 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||